Literature DB >> 1839880

Increased T lymphocytes bearing the gamma-delta T cell receptor in subjects at high risk for insulin dependent diabetes.

F P Lang1, D A Schatz, B H Pollock, W J Riley, N K Maclaren, M Dumont-Driscoll, D J Barrett.   

Abstract

The effector mechanisms responsible for autoimmune beta cell destruction in insulin dependent (type 1) diabetes (IDD) remain elusive. In order to investigate whether T lymphocytes bearing the gamma-delta T cell receptor (gamma delta+ T cells) could be involved in this process, we measured percentages of peripheral blood gamma delta+ T cells in IDD patients, relatives of IDD probands and controls. High levels of gamma delta+ T cells strongly differentiated 23 relatives at high risk for IDD on the basis of positive islet cell autoantibodies (ICA positive relatives) from 59 controls (P = 0.0013), whereas 26 ICA negative relatives, 14 recent-onset and nine long term IDD patients could not be distinguished from controls on the basis of percentages of gamma delta+ T cells. These data suggest that increased levels of circulating gamma delta+ T cells correlate with the ongoing autoimmune process in pancreatic islets of subjects at high risk for IDD and may thus represent an additional marker for the development of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839880     DOI: 10.1016/0896-8411(91)90055-h

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

Review 1.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

3.  Gamma delta lymphocytes in endocrine autoimmunity: evidence of expansion in Graves' disease but not in type 1 diabetes.

Authors:  I C Roura-Mir; L Alcalde; F Vargas; E Tolosa; G Obiols; M Foz; D Jaraquemada; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

4.  Gamma delta T cell receptors confer autonomous responsiveness to the insulin-peptide B:9-23.

Authors:  Li Zhang; Niyun Jin; Maki Nakayama; Rebecca L O'Brien; George S Eisenbarth; Willi K Born
Journal:  J Autoimmun       Date:  2010-01-18       Impact factor: 7.094

5.  Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes.

Authors:  Beverly Duncan; Cristina Nazarov-Stoica; Jacqueline Surls; Margaret Kehl; Constantin Bona; Sofia Casares; Teodor-D Brumeanu
Journal:  PLoS One       Date:  2010-07-02       Impact factor: 3.240

6.  Clonal expansions of activated gamma/delta T cells in recent-onset multiple sclerosis.

Authors:  R Shimonkevitz; C Colburn; J A Burnham; R S Murray; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.

Authors:  Julie Christine Antvorskov; Petra Fundova; Karsten Buschard; David P Funda
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

8.  Prevention or early cure of type 1 diabetes by intranasal administration of gliadin in NOD mice.

Authors:  David P Funda; Petra Fundova; Axel Kornerup Hansen; Karsten Buschard
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.